SAM
ELOS

Steinberg Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Steinberg Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-191,672
Closed -$2.36M – 65
2013
Q4 		$2.36M Sell
191,672
-8,315
-4% -$86.4K 0.13% 52
2013
Q3 		$1.72M Sell
199,987
-171,376
-46% -$1.48M 0.11% 54
2013
Q2 		$3.23M Buy
+371,363
New +$3.32M 0.22% 50

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return

Steinberg Asset Management's ELOS Position: Q1 2014 in Review

Steinberg Asset Management sold out of Syneron Medical Ltd (ELOS) in Q1 2014, closing a stake of 191,672 shares — an estimated $2.36M sold.

Steinberg Asset Management first reported a position in ELOS in Q2 2013 and held it in 3 quarters. The position peaked at $3.23M in Q2 2013. 71 funds tracked by Wall St. Rank hold ELOS as of Q1 2014.

  • Steinberg Asset Management reported no remaining Syneron Medical Ltd position as of Q1 2014 after selling out during the quarter.
  • Steinberg Asset Management sold 191,672 Syneron Medical Ltd shares in Q1 2014, an estimated $2.36M.
  • Steinberg Asset Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 3 quarters.
  • Steinberg Asset Management's Syneron Medical Ltd position peaked at $3.23M in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2014.

Based on Steinberg Asset Management's 13F filing for Q1 2014, filed 15 May 2014.